Journal of Labelled Compounds and Radiopharmaceuticals · 2003 · 33 citations · 10 references
PharmacyChemical BiologyMolecular BiologyGene ExpressionMolecular ImagingNucleic Acid BiochemistryNucleic Acid LabelingNucleic Acid SynthesisOligonucleotide ChemistryChemical Modification Of OligonucleotidesFluorine-18 ChemistryFluorine-18 LabelingOligonucleotide ConjugationOligonucleotide SynthesisPhosphorothioate ChemistryPhosphorothioate ModificationProtein Expression Levels
Abstract Labelled oligonucleotides are new imaging tools to study gene expression at the nucleic acid and protein levels. We have previously developed a universal method to label oligonucleotides at their 3′‐end with radiohalogens and particularly with fluorine‐18, the most widely used positron‐emitter, t 1/2 : 109.8 min. Using the same strategy, we herein report the fluorine‐18 labelling of oligonucleotides at their 5′‐end. A 18‐mer 2′O‐methyl modified oligoribonucleotide, bearing a phosphorothioate group at its 5′‐end, was conjugated to our fluorine‐18‐labelled reagent N ‐(4‐[ 18 F]fluorobenzyl)‐2‐bromoacetamide. The whole synthetic procedure yielded up to 1 GBq of fluorine‐18‐labelled oligonucleotide with a specific radioactivity of 37–74 GBq/μmol in 160 min. Copyright © 2003 John Wiley & Sons, Ltd.
10
In vivo imaging of oligonucleotides with positron emission tomography
Bertrand Tavitian, Salvatore Terrazzino, Bertrand Kühnast et al. · Nature Medicine · 1998 · 202 citations
Frédéric Dollé, Lilian Dolci, Héric Valette et al. · Journal of Medicinal Chemistry · 1999 · 125 citations · Full text